Source: International Congress 2017 – Pleural and mediastinal malignancies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Lagniau (Gent, Belgium). Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites. 4310

Member's Comments

No comment yet.

Related content which might interest you: In vitro discrimination between mesothelioma and lung cancer based on headspace volatile profiling Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021 Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Amorfous components of the extracellular matrix have impact as new biochemical markers on malignancy characterization and prognosis of non-small cell lung cancer Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: ERS Lung Science Conference 2017 Year: 2017 Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient Source: Eur Respir J , 49 (4)  1602149; DOI: 10.1183/13993003.02149-2016 Year: 2017 Volatile organic compounds in lung cancer patients before and after tumour resection Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 Clinical usefulness of natural killer cell activity in patients with non-small cell lung cancer Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Clinical implication of stem cell markers in N2 positive non-small cell lung cancer Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules Year: 2018 Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer? Source: Eur Respir J 2001; 18: Suppl. 33, 232s Year: 2001 Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients? Source: Eur Respir J 2015; 46: 1548-1550 Year: 2015